eFFECTOR Therapeutics Inc
(OTCPK:EFTR)
$
0.0505
-0.0097 (-16.11%)
Market Cap: 239,000.00
Enterprise Value: -4.85 Mil
PE Ratio: 0
PB Ratio: 0.24
GF Score: 0/100 - eFFECTOR Therapeutics Inc R&D Day TranscriptJan 24, 2024
- eFFECTOR Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- eFFECTOR Therapeutics Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- eFFECTOR Therapeutics Inc Provides Positive Clinical Data Update for Zotatifin and General Corporate Update Call TranscriptJan 05, 2023
- eFFECTOR Therapeutics Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- eFFECTOR Therapeutics Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- eFFECTOR Therapeutics Inc at JMP Securities Life Sciences Conference TranscriptJun 15, 2022
- eFFECTOR Therapeutics Inc Update on Expanded Development of Zotatifin - Corporate Call TranscriptJun 05, 2022
- eFFECTOR Therapeutics Inc Provides Pipeline and Business Updates - Conference Call TranscriptJan 24, 2022
eFFECTOR Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 26, 2023 / 07:00PM GMT
Release Date Price:
$12.93
(+0.45%)
Lucas Olson Duffy
Cantor Fitzgerald - Analyst
Good afternoon, everyone. Today, I'm here with eFFECTOR Therapeutics. My name is Lucas Olson Duffy. I'm a biotech and biopharma, large cap equity research associate on Louise Chen's team here at Cantor. So just to start off a little, could you introduce yourselves and tell us your roles at eFFECTOR?
Mike Byrnes
eFFECTOR Therapeutics, Inc. - CFO
Sure. Mike Byrnes, I'm the Chief Financial Officer at eFFECTOR. Got about 25 years experience in the industry. Joined eFFECTOR about three years ago.
Mayank Gandhi
eFFECTOR Therapeutics, Inc. - Chief Business Officer
Hi. I'm Mayank Gandhi. I'm the Chief Business Officer. Been at eFFECTOR for about a year and been in the industry for about 20 years or so.
Questions & Answers
Lucas Olson Duffy
Cantor Fitzgerald - Analyst
Wow, that's great. Thank you for the introduction. If we could just get straight into it. Can you tell us a little bit about eFFECTOR top-level view, just
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)